Literature DB >> 30371749

Array testing for multiplex assays.

Peijie Hou1, Joshua M Tebbs2, Dewei Wang2, Christopher S McMahan3, Christopher R Bilder4.   

Abstract

Group testing involves pooling individual specimens (e.g., blood, urine, swabs, etc.) and testing the pools for the presence of disease. When the proportion of diseased individuals is small, group testing can greatly reduce the number of tests needed to screen a population. Statistical research in group testing has traditionally focused on applications for a single disease. However, blood service organizations and large-scale disease surveillance programs are increasingly moving towards the use of multiplex assays, which measure multiple disease biomarkers at once. Tebbs and others (2013, Two-stage hierarchical group testing for multiple infections with application to the Infertility Prevention Project. Biometrics69, 1064-1073) and Hou and others (2017, Hierarchical group testing for multiple infections. Biometrics73, 656-665) were the first to examine hierarchical group testing case identification procedures for multiple diseases. In this article, we propose new non-hierarchical procedures which utilize two-dimensional arrays. We derive closed-form expressions for the expected number of tests per individual and classification accuracy probabilities and show that array testing can be more efficient than hierarchical procedures when screening individuals for multiple diseases at once. We illustrate the potential of using array testing in the detection of chlamydia and gonorrhea for a statewide screening program in Iowa. Finally, we describe an R/Shiny application that will help practitioners identify the best multiple-disease case identification algorithm.
© The Authors 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Case identification; Group testing; Infertility prevention project; Matrix pooling; Pooled testing; Screening

Mesh:

Year:  2020        PMID: 30371749      PMCID: PMC8978300          DOI: 10.1093/biostatistics/kxy058

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  28 in total

1.  Cost-effective pooling of DNA from nasopharyngeal swab samples for large-scale detection of bacteria by real-time PCR.

Authors:  Sophie Edouard; Elsa Prudent; Philippe Gautret; Ziad A Memish; Didier Raoult
Journal:  J Clin Microbiol       Date:  2014-12-31       Impact factor: 5.948

2.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

3.  Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Authors:  Robert D Kirkcaldy; Alesia Harvey; John R Papp; Carlos Del Rio; Olusegun O Soge; King K Holmes; Edward W Hook; Grace Kubin; Stefan Riedel; Jonathan Zenilman; Kevin Pettus; Tremeka Sanders; Samera Sharpe; Elizabeth Torrone
Journal:  MMWR Surveill Summ       Date:  2016-07-15

4.  Two-dimensional informative array testing.

Authors:  Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Biometrics       Date:  2011-12-29       Impact factor: 2.571

5.  The use of a square array scheme in blood testing.

Authors:  R M Phatarfod; A Sudbury
Journal:  Stat Med       Date:  1994-11-30       Impact factor: 2.373

6.  Optimal Configuration of a Square Array Group Testing Algorithm.

Authors:  Michael G Hudgens; Hae-Young Kim
Journal:  Commun Stat Theory Methods       Date:  2011-01-01       Impact factor: 0.893

7.  Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay.

Authors:  Annie Cheng; Qinfang Qian; James E Kirby
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

8.  Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.

Authors:  C A Gaydos; T C Quinn; D Willis; A Weissfeld; E W Hook; D H Martin; D V Ferrero; J Schachter
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Comparative analysis of triplex nucleic acid test assays in United States blood donors.

Authors:  Susan L Stramer; David E Krysztof; Jaye P Brodsky; Tracy A Fickett; Benjamin Reynolds; Roger Y Dodd; Steven H Kleinman
Journal:  Transfusion       Date:  2013-04-03       Impact factor: 3.157

10.  High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Authors:  Hideko Mine; Hiroyuki Emura; Masaki Miyamoto; Tsugikazu Tomono; Kiyoshi Minegishi; Hiroyuki Murokawa; Retsuji Yamanaka; Akira Yoshikawa; Kusuya Nishioka
Journal:  J Virol Methods       Date:  2003-09       Impact factor: 2.014

View more
  2 in total

1.  Simulation of group testing scenarios can boost COVID-19 screening power.

Authors:  Vinicius Henrique da Silva; Carolina Purcell Goes; Priscila Anchieta Trevisoli; Raquel Lello; Luan Gaspar Clemente; Talita Bonato de Almeida; Juliana Petrini; Luiz Lehmann Coutinho
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

2.  Application of dried blood spot sample pooling strategies for Plasmodium 18S rRNA biomarker testing to facilitate identification of infected persons in large-scale epidemiological studies.

Authors:  Ming Chang; Selena Johnston; Annette M Seilie; Dianna Hergott; Sean C Murphy
Journal:  Malar J       Date:  2021-10-07       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.